Marché des vaccins à base de plantes – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00024327
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 243
Buy Now

[Rapport de recherche]Le marché des vaccins à base de plantes devrait atteindre 2 672,05 millions de dollars américains d'ici 2028, contre 1 143,72 millions de dollars américains en 2021. Le marché devrait croître à un TCAC de 12,9 % de 2021 à 2028.

La portée du marché des vaccins à base de plantes comprend le type de vaccin, la source, l'application et la géographie. En fonction de la région, le marché des vaccins à base de plantes est segmenté en Amérique du Nord, en Europe, en Asie-Pacifique, au Moyen-Orient et en Afrique et en Amérique du Sud et centrale. Le rapport offre des informations et une analyse approfondie du marché des vaccins à base de plantes, en mettant l'accent sur divers paramètres tels que les tendances et les opportunités du marché, la dynamique du marché et l'analyse du paysage concurrentiel des principaux acteurs du marché en Amérique du Nord, en Europe, en Asie-Pacifique, au Moyen-Orient et Afrique et Amérique du Sud et centrale. Il comprend également une analyse de l'impact du COVID-19 dans les régions.



Aperçus stratégiques



Régions lucratives pour le marché des vaccins à base de plantes



Aperçus du marché



< h3>Nombre croissant d'activités de recherche et développement (R&D) dans les vaccins à base de plantes

Le manque de vaccins pour prévenir les maladies mortelles a créé des problèmes et a suscité une attention mondiale sur le développement de vaccins plus sûrs, plus faciles et plus efficaces. vaccins efficaces. Les plantes sont parmi les créateurs de protéines les plus prolifiques au monde. Les plantes expriment efficacement des protéines de divers modèles de complexité et de glycosylation. La technologie recombinante est utilisée pour créer des vaccins dérivés de plantes, dans lesquels le gène codant pour la protéine antigénique requise est incorporé dans le génome de la plante. De plus, les experts estiment que la production d'un vaccin à base de plantes prend cinq à six semaines au lieu des cinq à six mois requis par les fabricants de vaccins pour préparer le vaccin dans des œufs de poule. De nombreux pays dans le monde développent un vaccin efficace pour lutter contre la propagation du COVID-19, et les vaccins à base de plantes sont l'une des options pour le développement de vaccins. Les vaccins à base de plantes ont une bonne réputation parmi les chercheurs en raison de leur procédure de fabrication réussie bien connue et de leur faible coût. Diverses recherches et essais cliniques sont menés pour le développement de vaccins à base de plantes. Par exemple, Medicago Inc., une société de biotechnologie au stade clinique qui utilise des technologies à base de plantes pour développer et produire de nouveaux vaccins et anticorps, a produit avec succès des particules pseudo-virales (VLP) du nouveau coronavirus à peine 20 jours après avoir obtenu le SARS-CoV- gène 2 (le virus responsable de la maladie COVID-19). Les acteurs de premier plan existants et les nouveaux entrants sur le marché des vaccins à base de plantes concentrent leurs efforts sur la réalisation d'essais cliniques complets pour produire des vaccins à base de plantes pour une variété d'applications thérapeutiques. Par conséquent, le nombre croissant d'activités de recherche et développement (R&D) dans les vaccins à base de plantes augmentera considérablement la demande de vaccins à base de plantes dans le monde entier, entraînant une poussée à la hausse de la croissance du marché.



Vaccin Aperçus basés sur le type



En fonction du type de vaccin, le marché des vaccins à base de plantes est segmenté en vaccins bactériens, vaccins viraux, vaccins antiparasitaires, particules virales dérivées de plantes (VLPS) et autres. Le segment des vaccins bactériens détenait la plus grande part du marché en 2021. Cependant, le segment des particules pseudo-virales (VLP) d'origine végétale devrait enregistrer le TCAC le plus élevé de 13,6 % sur le marché au cours de la période de prévision.



Marché des vaccins à base de plantes, par type de vaccin - 2021 et 2028



Informations basées sur la source



Sur la base de la source, le marché des vaccins à base de plantes est segmenté en plante de tabac, maïs, pomme de terre et autres. Le segment des plants de tabac détenait la plus grande part du marché en 2021, et le même segment devrait enregistrer le TCAC le plus élevé de 13,3 % du marché au cours de la période de prévision.



Application-Based Insights

Sur la base des applications, le marché des vaccins à base de plantes est segmenté en grippe, virus zika, virus Ebola, maladie de la volaille, COVID-19 et autres. Le segment de la grippe détenait la plus grande part du marché en 2021. Cependant, le segment COVID-19 devrait enregistrer le TCAC le plus élevé de 13,8 % sur le marché au cours de la période de prévision.



Les entreprises adoptent généralement des stratégies inorganiques telles que les fusions et acquisitions pour répondre à l'évolution de la demande des clients et maintenir leur marque dans le monde entier. Les acteurs du marché opérant sur le marché des vaccins à base de plantes adoptent également des stratégies organiques telles que le lancement et l'expansion de produits pour étendre leur empreinte et leur portefeuille de produits dans le monde entier et répondre à la demande croissante.



Par type de vaccin



  • Vaccins bactériens

  • Vaccins viraux

  • Vaccins antiparasitaires

  • Particules pseudo-virales dérivées de plantes (VLP)

  • Autres< /li>

Par source




  • Plant de tabac

  • Maïs

  • Pomme de terre

  • Autres

Par application




  • Grippe

  • Virus Zika

  • Virus Ebola

  • COVID-19

  • Maladies de la volaille

  • Autres


Par géographie




  • Amérique du Nord
    • États-Unis< /li>
    • Canada

    • Mexique



  • Europe
    • Royaume-Uni

    • Allemagne

    • France

    • Italie

    • Espagne

    • Reste de l'Europe



  • Asie-Pacifique
    • Chine

    • Japon

    • Inde

    • Australie

    • Corée du Sud

    • Reste de l'Asie-Pacifique

    • li>


  • Moyen-Orient et Afrique
    • Arabie saoudite

    • Afrique du Sud

    • EAU

    • Reste du Moyen-Orient et de l'Afrique



  • Amérique du Sud et centrale
    • Brésil

    • Argentine

    • Reste de l'Amérique du Sud et centrale Amérique centrale




Profils des entreprises




  • MEDICAGO, INC.

  • British American Tobacco plc
  • ICON GENETICS GMBH

  • CREATIVE BIOLABS, INC.

  • iBio, Inc.

  • LENIOBIO

  • Lumen Bioscience, Inc. .

  • LEAF EXPRESSION SYSTEMS LTD.

  • ZYUS LIFE SCIENCES INC.

  • FRAUNHOFER CMB


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which source is expected to dominate the market in the forecast period in Plant-Based Vaccines market?

The market is led by source tobacco plant segment is growing significantly due to the increasing use of tobacco plants in pharmaceuticals. The growing research in pharmaceutical is playing a vital role in developing new vaccines. For instance the U.S Department of Agriculture approved a plant-based vaccine for Newcastle disease that infected poultry and produced it in suspension-cultured tobacco cells.

What will be the CAGR of Plant-Based Vaccines market?

The market is estimated to grow with a CAGR of 12.9% from 2021 to 2028.

What are the driving factors for the Plant-based Vaccines market across the globe?

Key factors that are driving growth of the market are increasing number of research & development (R&D) activities in plant-based vaccines and growing prevalence of infectious diseases market fuel the growth of the market.

What are Plant-Based Vaccines?

Plant-based vaccines can be made cheaply and produced on a large scale. These vaccines have several advantages, including being readily accepted by patients and stable for long-term antigen storage. These also help to reduce the economic burden of infectious disease globally. Various plants have developed plant-derived vaccines such as potato, rice, maize, tomato, carrot, tobacco, soybean, and peanut. The choice of the plant depends on the route of administration of the vaccine.

The List of Companies - Plant-based Vaccines Market

  1. MEDICAGO, INC.
  2. British American Tobacco p.l.c.          
  3. ICON GENETICS GMBH
  4. CREATIVE BIOLABS, INC.      
  5. iBio, Inc.
  6. LENIOBIO
  7. Lumen Bioscience, Inc.
  8. LEAF EXPRESSION SYSTEMS LTD.
  9. ZYUS LIFE SCIENCES INC.
  10. FRAUNHOFER CMB

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports